FindTrial
Sign In

Effects of a combined online and face-to-face group acceptance commitment therapy intervention on post-traumatic stress disorder symptoms in breast cancer patients with neurotic personality tendencies: a randomized controlled trial

An intervention study of Acceptance Commitment Therapy for post-traumatic stress disorder in breast cancer patients with neurotic personality tendencies

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078760
Enrollment
Unknown
Registered
2023-12-18
Start date
2023-12-18
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

control group:Routine psychological care
intervention group:Acceptance and Commitment Therapy (ACT) + Routine psychological care

Sponsors

The First Affiliated Hospital of Dali University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria for breast cancer; ? Age =18 years; ? Score =38 on the Post-Traumatic Stress Disorder Inventory-Civilian Version; ? Score of The Eysenck Personality Questionnaire Short Form Scale, Chinese Version-Neuroticism subscale >= 56.7; ? Able to understand the informed consent and the related study content.

Exclusion criteria

Exclusion criteria: ?critically ill and unable to participate in the study; ?co-morbid with other serious physical diseases; ? co-morbid with other serious mental illnesses; ? patients with mental retardation and intellectual disabilities; ?concurrently undergoing other related psychological interventions.

Design outcomes

Primary

MeasureTime frame
post-traumatic stress disorder;—

Secondary

MeasureTime frame
Social Support;Coping Style;Self-Efficacy;Neuroticism;—

Countries

China

Contacts

Public ContactQiao Zhou

The First Affiliated Hospital of Dali University; Dali University

1761282596@qq.com+86 183 0831 2160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026